Related Experiment Video
Updated: Sep 6, 2025
In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow
Published on: March 14, 2021
Vasculogenic Mimicry in a 3D Model In Vitro
Emily Marques Dos Reis1, Fernanda Vieira Berti2, Luismar Marques Porto2
1Chemical and Food Engineering Department, Federal University of Santa Catarina, Florianópolis, SC, Brazil. emimreis@gmail.com.
This study presents a 3D model to mimic vasculogenic mimicry (VM) in vitro. The model incorporates a hypoxic microenvironment and endothelial cells, crucial for understanding tumor aggressiveness.
Area of Science:
- Oncology
- Cell Biology
- Biomedical Engineering
Background:
- Vasculogenic mimicry (VM) is linked to tumor aggressiveness.
- Tumor phenotype is regulated by the hypoxic microenvironment and endothelial cells.
- Accurate in vitro models are needed to study VM.
Purpose of the Study:
- To develop a robust 3D in vitro model for mimicking vasculogenic mimicry (VM).
- To incorporate key factors influencing VM, including hypoxia and endothelial cells.
Main Methods:
- Utilized a 3D matrix model.
- Incorporated melanoma cells and endothelial cells.
- Introduced a hypoxia-inducing agent to simulate the tumor microenvironment.
Main Results:
- Successfully established a 3D in vitro system that mimics key aspects of VM.
- The model integrates cellular components and environmental factors relevant to VM.
- Provides a platform for studying VM in a controlled setting.
Conclusions:
- The developed 3D model offers a more robust approach to mimicking VM in vitro.
- This model facilitates research into the role of hypoxia and endothelial cells in tumor aggressiveness.
- It serves as a valuable tool for investigating VM-related cancer biology.
More Related Videos
06:36An In Vitro 3D Model and Computational Pipeline to Quantify the Vasculogenic Potential of iPSC-Derived Endothelial Progenitors
Published on: May 13, 2019
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021